An esteemed, dependable, and rapidly expanding pharmaceutical company from Turkey established in 2007 (with origins dating back to 1952), operating domestically and internationally. The company's manufacturing facility, acquired from Novartis Gr. in 2020, boasts 19 years of global CMO/CDMO experience, is compliant in 123 nations, and actively exports to 86 countries. It adheres to European GMP standards, excels in competency and efficiency, and maintains a high service level.
Genveon İlaç
Manufacturer
Headquarters
Türkiye